Acura Pharmaceuticals, Inc. Stock
Stocks
ACUR
US00509L8028
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
12:35:26 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 0.000101 USD | -.--% |
|
-0.99% | -80.00% |
| Market Cap | 3.28M 2.91M 2.72M 2.48M 4.67M 316M 4.74M 32.94M 12.75M 161M 12.31M 12.04M 516M | P/E 2020 |
-5.25x | P/E 2021 | -25x |
|---|---|---|---|---|---|
| Enterprise Value | 3.41M 3.03M 2.84M 2.58M 4.86M 329M 4.93M 34.3M 13.28M 167M 12.82M 12.54M 538M | EV / Sales 2020 |
2.91x | EV / Sales 2021 | 20.9x |
| Free-Float |
98.31% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 week | -0.99% | ||
| Current month | -0.99% | ||
| 3 months | -88.89% | ||
| 6 months | -99.00% | ||
| Current year | -80.00% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.01 |
| 3 years | 0 | | 0.75 |
| 5 years | 0 | | 0.75 |
| 10 years | 0 | | 1.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 67 | 2011-03-31 |
Bob Seiser
DFI | Director of Finance/CFO | 62 | 2024-07-31 |
Albert Brzeczko
CTO | Chief Tech/Sci/R&D Officer | 69 | 2009-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
William Skelly
CHM | Chairman | 75 | 1996-09-30 |
| Director/Board Member | 55 | 2002-11-30 | |
Bruce Wesson
BRD | Director/Board Member | 83 | 1998-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/2/26 | Exercice | Director | 150,000 | 0.2273% | ||
| 1/2/26 | Exercice | Director | 150,000 | 0.2273% | ||
| 1/2/26 | Exercice | Director | 150,000 | 0.2273% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -0.99% | -75.00% | -75.00% | 6.73K | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -1.14% | -1.54% | +24.43% | +78.20% | 59.26B | |
| +1.03% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 42.91B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 44.13B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 40.79B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +22.72% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 23.71B | |
| Average | -0.48% | -0.47% | +40.05% | +131.17% | 39.24B | |
| Weighted average by Cap. | +0.01% | -0.32% | +58.01% | +145.76% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 3.57M 3.17M 2.97M 2.7M 5.09M 344M 5.16M 35.87M 13.89M 175M 13.4M 13.11M 562M | 1.56M 1.39M 1.3M 1.18M 2.23M 150M 2.26M 15.71M 6.08M 76.64M 5.87M 5.74M 246M |
| Net income | -1.21M -1.07M -1M -914K -1.72M -116M -1.75M -12.14M -4.7M -59.23M -4.54M -4.44M -190M | -879K -781K -730K -665K -1.25M -84.63M -1.27M -8.83M -3.42M -43.1M -3.3M -3.23M -138M |
| Net Debt | 5.86M 5.2M 4.86M 4.43M 8.34M 564M 8.46M 58.84M 22.78M 287M 21.99M 21.51M 922M | 135K 120K 112K 102K 192K 13M 195K 1.36M 525K 6.62M 507K 496K 21.26M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | US$0.000101 | -.--% | 120 |
| 26-09-25 | US$0.000101 | -.--% | 300 |
| 26-09-24 | US$0.000101 | +1.00% | 1,050 |
- Stock Market
- Stocks
- ACUR Stock
Select your edition
All financial news and data tailored to specific country editions
